Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
Rank in Stocks #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Share Price
$0.1458359
Last synced: 2026-08-21
Market Cap
$85.87M
Change (1 day)
-1.30%
Change (1 year)
-38.40%
Country
HK
Trade Lee's Pharmaceutical Holdings Limited (0950)

Category

Price of 0950 with the market cap of B
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
0950
$0.1458359
Market Capitalization of Lee's Pharmaceutical Holdings Limited(0950)
Market Cap: $85.87M
As of August 2026 Lee's Pharmaceutical Holdings Limited has a market cap of $85.87M. This makes Lee's Pharmaceutical Holdings Limited the world's 22620th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lee's Pharmaceutical Holdings Limited from 2002 to 2026
0950 compared with Top 5 Most Popular stocks
Price of 0950 Asset B Mkt. of B Results
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$8,850.34 $85.87M
$5.211T +6,068,594.72%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,721.62 $85.87M
$4.547T +5,294,634.25%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,069.03 $85.87M
$4.162T +4,847,147.71%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$6,101.55 $85.87M
$3.593T +4,183,743.16%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$4,743.03 $85.87M
$2.793T +3,252,208.68%